« Back
Home /
Codrituzumab Biosimilar(Anti-GPC3 / Glypican-3 Reference Antibody)

Codrituzumab Biosimilar(Anti-GPC3 / Glypican-3 Reference Antibody)

Item no.	DCC-A151-1mg
Manufacturer	DCChemicals
CASRN	1365267-33-9
Amount	1 mg
Quantity options	100 mg 10 mg 1 mg 5 mg
Category	Oncology Neuroscience Neural Signaling By Cell Type Blastoma Carcinoma
Specific against	other
Available
Manufacturer - Applications	Codrituzumab (GC33) is a humanized monoclonal antibody targeting human GPC3 (glypican-3), with high affinity (Kd of 0.673 nM). GPC3 is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Delivery expected until 10/9/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer